Caribou Biosciences (CRBU) Asset Utilization Ratio (2021 - 2026)

Caribou Biosciences (CRBU) has 6 years of Asset Utilization Ratio data on file, last reported at 0.07 in Q1 2026.

• Quarterly Asset Utilization Ratio rose 104.4% year-over-year to 0.07 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.07 (up 104.4% YoY) and the FY2025 annual result came in at 0.05, up 70.34% from the prior year.
• Asset Utilization Ratio advanced to 0.07 in Q1 2026 per CRBU's latest filing, from 0.06 in the prior quarter.
• Across five years, Asset Utilization Ratio topped out at 0.09 in Q3 2023 and bottomed at 0.02 in Q1 2022.
• The 5-year median for Asset Utilization Ratio is 0.04 (2023), against an average of 0.05.
• The widest annual swing landed in 2023, when Asset Utilization Ratio soared 176.53%; it then slumped 62.69% in 2024.
• Tracing CRBU's Asset Utilization Ratio over 5 years: stood at 0.04 in 2022, then surged by 116.14% to 0.08 in 2023, then plunged by 60.78% to 0.03 in 2024, then jumped by 98.27% to 0.06 in 2025, then climbed by 14.63% to 0.07 in 2026.
• Per Business Quant, the three latest CRBU Asset Utilization Ratio figures stand at 0.07 (Q1 2026), 0.06 (Q4 2025), and 0.04 (Q3 2025).

Peer Comparison